The Bear Cave #345

Blue Orca and Iceberg Research published reports on EquipmentShare.com (EQPT) and Deep Fission (FISN), alleging financial and operational issues. EquipmentShare disputes the claims. Viceroy and Scorpion Capital raised concerns about Blue Moon Metals (BMM) and Twist Bioscience (TWST). Several companies, including Corcept Therapeutics (CORT), Nutanix (NTNX), and Zscaler (ZS), reported executive departures. Michael Burry warned of $3 trillion in AI-related commitments across major tech firms.

Original reporting
Published Sep 27, 2026, 2:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 27, 2026, 5:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
The Bear Cave #345 — source image
Decision brief

The 30-second read

$EQPTBearishLow
01

Why it matters

Collectively, the items suggest heightened scrutiny and leadership turnover, which may pressure share prices in the short term.

02

Market read

While each item is individually modest, the aggregation signals a broader risk theme for small‑cap US equities.

03

What to watch

Potential strategic pivots or financing solutions not yet disclosed could mitigate the highlighted risks.

Relevance 4/10Novelty 2/10Timing: none

Background

The Bear Cave newsletter aggregates recent activist reports, regulatory inquiries, and executive departures across a range of US‑listed companies.

Company-level read

Ticker impact

$EQPTBearishMedium confidence
Context

Blue Orca activist report alleges undisclosed liabilities in EquipmentShare's OWN program.

Expected impact

likely pressure as market prices in potential liability risk

Evidence & confidence

Report raises questions about $500 M exposure versus $55 M book value.

$FISNBearishMedium confidence
Context

Iceberg Research questions Deep Fission's reactor cost assumptions and capital adequacy.

Expected impact

likely pressure from doubts over financial viability

Evidence & confidence

Research flags $350 M funding gap versus disclosed cash.

$BMMBearishMedium confidence
Context

Viceroy Research asks Ontario regulator to review Blue Moon Metals' project financing claims.

Expected impact

potential pressure pending regulator action

Evidence & confidence

Investigation request signals possible misstatements.

$TWSTBearishMedium confidence
Context

Scorpion Capital flagged a $56.3 M stock sale by Twist Bioscience CEO under a 10b5‑1 plan.

Expected impact

likely pressure as market absorbs sale volume

Evidence & confidence

Sale size and timing raise concerns.

$CORTBearishMedium confidence
Context

President of Corcept Endocrinology resigned; insiders have been heavy sellers.

Expected impact

likely pressure from leadership change

Evidence & confidence

Resignation and insider sales suggest weakening confidence.

$NTNXBearishLow confidence
Context

President and Chief Commercial Officer of Nutanix will step down.

Expected impact

potential modest pressure

Evidence & confidence

Departure noted without further context.

$ZSBearishLow confidence
Context

Chief Revenue Officer of Zscaler is stepping down for personal reasons.

Expected impact

likely modest pressure

Evidence & confidence

No additional catalyst beyond resignation.

$PRKSBearishLow confidence
Context

Chief Commercial Officer of United Parks & Resorts resigned after short notice.

Expected impact

potential pressure

Evidence & confidence

Resignation noted amid broader turnover.

Market effects

Activist scrutiny across equipment‑rental, nuclear‑tech, and biotech sectors may heighten risk awareness.

Primarily U.S. listed firms; limited broader regional effect.

Limited to investors tracking US‑listed small‑cap exposure.

Counterpoint

Some investors may view the activist reports as overblown, seeing buying opportunities on dip.

Key entities

  • Blue Orca

    Research firm publishing report on EquipmentShare.

  • Iceberg Research

    Published critical analysis of Deep Fission.

Related articles

$EQPTMedAI 8/10

EquipmentShare.com Q3 Earnings Call Highlights

EquipmentShare reported Q3 revenue of $900M, up from $550M a year earlier. The company operates 448 locations, with mature sites showing a 54% Adjusted Core EBITDA margin. Sales reached $294M, with $243M from its OWN Program. Full-year guidance remains at $5.9B revenue and $2.2B Adjusted Core EBITDA. The company expects to end the year with $11.5B in managed fleet OEC and leverage in the low three-times range. Advanced Solutions revenue doubled, driven by power generation demand.

$EQPTLow

Why EquipmentShare.com Stock Crashed Today

EquipmentShare.com (EQPT) stock fell 21% Tuesday despite beating Q3 earnings estimates. The company reported $0.16 EPS on $1.5B revenue, but GAAP net income was only $0.03 per share. Free cash flow was negative, with a $1.1B cash burn so far this year. Revenue grew 55% YoY, but investors focused on earnings quality concerns.

$EQPTHighAI 8/10

Why is EquipmentShare stock plunging today?

EquipmentShare (EQPT) shares dropped 22.2% after Q3 2026 earnings beat estimates but failed to reassure investors due to capital expenditure concerns and unchanged full-year guidance. Analysts cut price targets, and broader market declines added pressure. The stock hit a 52-week low of $12.41.

$EQPTMedAI 8/10

EquipmentShare 3Q 2026: Revenue $1.47B — 10-Q Summary

EquipmentShare reported 3Q 2026 revenue of $1.47B, up year over year, driven by construction demand, fleet expansion, and higher equipment sales. Net income also rose, though offset by increased expenses. The company expanded to 408 branches and 302,865 units under management. Equipment rental revenue grew 47%, and sales revenue increased 76%, with a $139M rise in construction equipment sales to OWN Program participants.